Cargando…
From Bench to Bedside: Lessons Learned in Translating Preclinical Studies in Cancer Drug Development
The development of targeted agents in oncology has rapidly expanded over the past 2 decades and has led to clinically significant improvements in the treatment of numerous cancers. Unfortunately, not all success at the bench in preclinical experiments has translated to success at the bedside. As pre...
Autores principales: | Lieu, Christopher H., Tan, Aik-Choon, Leong, Stephen, Diamond, Jennifer R., Eckhardt, S. Gail |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787906/ https://www.ncbi.nlm.nih.gov/pubmed/24052618 http://dx.doi.org/10.1093/jnci/djt209 |
Ejemplares similares
-
Intensification of Androgen Deprivation Therapy in High-Risk, Nonmetastatic Prostate Cancer: Lessons From STAMPEDE
por: Gong, Jun, et al.
Publicado: (2022) -
Translating atherosclerosis research from bench to bedside: navigating the barriers for effective preclinical drug discovery
por: May, Lauren T., et al.
Publicado: (2022) -
Immunogenicity of two different hepatitis B vaccine schedules
por: Agladioglu, S. Y., et al.
Publicado: (2011) -
Making Breast Cancer Molecular Subtypes Robust?
por: Staaf, Johan, et al.
Publicado: (2014) -
A Think Tank of TINK/TANKs: Tumor-Infiltrating/Tumor-Associated Natural Killer Cells in Tumor Progression and Angiogenesis
por: Bruno, Antonino, et al.
Publicado: (2014)